These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15554027)

  • 1. Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences.
    Olivotto I; Cecchi F; Camici PG
    Ital Heart J; 2004 Aug; 5(8):572-80. PubMed ID: 15554027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy.
    Cecchi F; Sgalambro A; Baldi M; Sotgia B; Antoniucci D; Camici PG; Sciagrà R; Olivotto I
    J Cardiovasc Transl Res; 2009 Dec; 2(4):452-61. PubMed ID: 20560003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myocardial hypoperfusion due to microvascular dysfunction in hypertrophic cardiomyopathy: role of positron emission tomography].
    Cecchi F; Olivotto I; Baldi M; Maron MS; Maron BJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1069-73. PubMed ID: 20193174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography.
    Timmer SA; Knaapen P
    Eur Heart J Cardiovasc Imaging; 2013 Feb; 14(2):95-101. PubMed ID: 23152441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.
    Cecchi F; Olivotto I; Gistri R; Lorenzoni R; Chiriatti G; Camici PG
    N Engl J Med; 2003 Sep; 349(11):1027-35. PubMed ID: 12968086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy.
    Olivotto I; Cecchi F; Gistri R; Lorenzoni R; Chiriatti G; Girolami F; Torricelli F; Camici PG
    J Am Coll Cardiol; 2006 Mar; 47(5):1043-8. PubMed ID: 16516091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.
    Knaapen P; Germans T; Camici PG; Rimoldi OE; ten Cate FJ; ten Berg JM; Dijkmans PA; Boellaard R; van Dockum WG; Götte MJ; Twisk JW; van Rossum AC; Lammertsma AA; Visser FC
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H986-93. PubMed ID: 18156203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron-emission tomography myocardial blood flow quantification in hypertrophic cardiomyopathy.
    Sciagrà R
    Q J Nucl Med Mol Imaging; 2016 Dec; 60(4):354-61. PubMed ID: 27611709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary microvascular dysfunction in hypertrophic cardiomyopathy: Pathophysiology, assessment, and clinical impact.
    Aguiar Rosa S; Rocha Lopes L; Fiarresga A; Ferreira RC; Mota Carmo M
    Microcirculation; 2021 Jan; 28(1):e12656. PubMed ID: 32896949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
    Choudhury L; Rosen SD; Patel D; Nihoyannopoulos P; Camici PG
    Eur Heart J; 1997 Jan; 18(1):108-16. PubMed ID: 9049522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.
    Bravo PE; Zimmerman SL; Luo HC; Pozios I; Rajaram M; Pinheiro A; Steenbergen C; Kamel IR; Wahl RL; Bluemke DA; Bengel FM; Abraham MR; Abraham TP
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):210-7. PubMed ID: 23418294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The case for myocardial ischemia in hypertrophic cardiomyopathy.
    Maron MS; Olivotto I; Maron BJ; Prasad SK; Cecchi F; Udelson JE; Camici PG
    J Am Coll Cardiol; 2009 Aug; 54(9):866-75. PubMed ID: 19695469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
    Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
    Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic compression of epicardial coronary and intramural arteries in children with hypertrophic cardiomyopathy.
    Mohiddin SA; Fananapazir L
    Tex Heart Inst J; 2002; 29(4):290-8. PubMed ID: 12484613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography.
    Camici P; Chiriatti G; Lorenzoni R; Bellina RC; Gistri R; Italiani G; Parodi O; Salvadori PA; Nista N; Papi L
    J Am Coll Cardiol; 1991 Mar; 17(4):879-86. PubMed ID: 1999624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syncope and ventricular arrhythmias in hypertrophic cardiomyopathy are not related to the derangement of coronary microvascular function.
    Lorenzoni R; Gistri R; Cecchi F; Olivotto I; Chiriatti G; Elliott P; McKenna WJ; Camici PG
    Eur Heart J; 1997 Dec; 18(12):1946-50. PubMed ID: 9447323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular dysfunction in hypertrophic cardiomyopathy evaluated by cardiac magnetic resonance and computed tomography.
    Moral S; Fernandez-Friera L; Sanz J
    Acta Cardiol; 2010 Jun; 65(3):367-9. PubMed ID: 20666282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy?
    Bravo PE
    J Nucl Cardiol; 2019 Aug; 26(4):1125-1134. PubMed ID: 29761309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia.
    Schwartzkopff B; Mundhenke M; Strauer BE
    J Am Coll Cardiol; 1998 Apr; 31(5):1089-96. PubMed ID: 9562012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.